What are the Challenges in Using Antiviral Therapies for Cancer Prevention and Treatment?
Despite their potential, there are several challenges in using antiviral therapies for cancer prevention and treatment. Drug resistance is a significant issue, as viruses can mutate and become resistant to existing antiviral drugs. Additionally, the long-term use of antiviral drugs can lead to side effects and toxicity. There is also the challenge of ensuring widespread access to antiviral therapies and vaccines, particularly in low-resource settings where the burden of virus-related cancers is often higher.
